Alpharma AS

Profile
More about Alpharma
  • News

    King Proposes Acquisition of Alpharma for $33 Per Share in Cash

    King Pharmaceuticals, Inc. announced that it has submitted to the Board of Directors of Alpharma Inc.a proposal to acquire all of the outstanding shares of common stock of Alpharma for $33.00 per share in cash. The proposal is not conditioned on financing. King’s all-cash proposal represent ... more

    Alpharma announces sale of Aquatic Operations, Norway

    Alpharma Inc. announced that it has completed the sale of the aquatic animal health operations of its Animal Health business to an employee group. The aquatic operations, which are headquartered in Oslo, Norway, manufacture and market vaccines primarily for use in immunizing farmed fish wor ... more